Indirect and competitive enzyme-linked immunosorbent assays for monitoring the humoral response against human VEGF.
J Immunoassay Immunochem
; 37(6): 636-58, 2016.
Article
em En
| MEDLINE
| ID: mdl-27143151
CIGB-247, a VEGF-based vaccine, was studied in a clinical trial. This advance demands the refinement of the methodologies for assessment of vaccine immune responses. This study aimed to improve the performance of ELISAs for detecting IgG antibodies against human VEGF and the blocking activity of the serum to inhibit the VEGF/VEGFR2 interaction. The best experimental conditions were established through the evaluation of several blocking buffers, immobilization surfaces, and plate suppliers using human sera as test samples. As a result, two controlled ELISAs were used in testing of elicited immune response against VEGF in patients immunized with CIGB-247.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Ensaio de Imunoadsorção Enzimática
/
Vacinas Anticâncer
/
Receptor 2 de Fatores de Crescimento do Endotélio Vascular
/
Fatores de Crescimento do Endotélio Vascular
/
Imunidade Humoral
Tipo de estudo:
Clinical_trials
Limite:
Animals
/
Humans
Idioma:
En
Revista:
J Immunoassay Immunochem
Assunto da revista:
ALERGIA E IMUNOLOGIA
Ano de publicação:
2016
Tipo de documento:
Article
País de afiliação:
Cuba
País de publicação:
Reino Unido